Phosphate Imbalance | Hypophosphatemia vs Hyperphosphatemia | Electrolyte Imbalances
#PhosphateImbalance #ElectrolyteImbalance #Hypophosphatemia #Hyperphosphatemia #Electrolytes #MedicalEducation #NursingEducation #NursingNotes #MedicalNotes #VikaasShandily

severe hypocalcemia, #hyperphosphatemia & low parathyroid hormone levels during COVID infection .
The authors hypothesize that the dysregulation, particularly hypocalcemia, may contribute to increased disease severity in Fahr's syndrome patients with #COVID .

Phosphate Imbalance: Hypophosphatemia vs Hyperphosphatemia
#iPrkashMishra #PhosphateImbalance #Hypophosphatemia #Hyperphosphatemia #ElectrolyteImbalance #MedicalStudents #NursingEducation #MedNotes

Abul Fajol et al. observed that soft tissue accumulations of phosphate are not always associated with serum phosphate or with calcifications in mouse models of #hyperphosphatemia 💉 🔎

📜 Read the #Research here: physoc.onlinelibrary.wiley.com/doi/10.1113/...

Alebund Unveils Promising Phase 3 AP301 Trial Results at ASN 2025 Congress in Houston Alebund Pharmaceuticals presented significant Phase 3 trial results for AP301 at the ASN 2025 Congress, showcasing its ability to reduce serum phosphate levels effectively.

Alebund Unveils Promising Phase 3 AP301 Trial Results at ASN 2025 Congress in Houston #China #Houston #Alebund #AP301 #Hyperphosphatemia

Ultraprocessed Foods Linked to Hyperphosphatemia Among Patients Receiving Hemodialysis | Docwire News A study of Brazilian patients tied eating more ultraprocessed foods to higher odds of hyperphosphatemia among patients receiving hemodialysis.

ICYMI: Eating more ultraprocessed foods was tied to higher odds of #hyperphosphatemia among patients receiving #hemodialysis. #nephrology #nephsky #ultraprocessedfoods docwirenews.com/post/ultrapr...

Alebund Pharmaceuticals Achieves Success in Phase 3 Study of AP301 for Dialysis Patients Alebund Pharmaceuticals has shared promising results from its Phase 3 trial of AP301, a novel treatment for hyperphosphatemia in dialysis patients. The drug shows significant improvements in phosphorus control.

Alebund Pharmaceuticals Achieves Success in Phase 3 Study of AP301 for Dialysis Patients #China #Shanghai #Alebund #AP301 #Hyperphosphatemia

Struggling with hyperphosphatemia in dialysis patients? 🦴🫘

Meet #Tenapanor!

It inhibits paracellular phosphate absorption by modulating NHE3 & tight junctions.

A novel way to tackle phosphorus! 🔬💊

#Nephrology #Hyperphosphatemia #Dialysis #HD

📖https://doi.org/10.1053/j.jrn.2024.07.003

Retained black residues seen on flexible sigmoidoscopy.

The potential of sucroferric oxyhydroxide use to result in poor bowel preparation resulting in inadequate visualization on lower gastrointestinal endoscopy.

@csnscn.bsky.social @cjkhd.bsky.social

DOI:
doi.org/10.1177/2054...

#Sigmoidoscopy
#ESKD
#hyperphosphatemia
#Sucroferricoxyhydroxide